Deerfield Mgmt HIF, L.P. (CIK 0001665736)

Latest company ownership

Shares held
4,721,197
Last filed at
Feb 16, 2024
Confidence Score
59.4
2025Q4
Confidence Score History
2021Q2 2025Q4
QTTB - Q32 Bio Inc.
Role: 10% Owner
Shares held
4,087,305
Last filed at
Jan 31, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q2 2025Q4
Shares held
1,540,190
Last filed at
Jun 8, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q3 2025Q4
Shares held
854,700
Last filed at
Feb 8, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q1 2025Q4
NUVL - Nuvalent, Inc.
Role: Director
Shares held
650,000
Last filed at
Nov 24, 2025
Confidence Score
23.6
2025Q4
Confidence Score History
2022Q4 2025Q4
CALC - CalciMedica, Inc.
Role: 10% Owner
Shares held
291,467
Last filed at
Oct 1, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 24, 2025 Nov 24, 2025 Nuvalent, Inc. Director Sell 15.0 -742,574 -4.13% ✗ $70.9M
Jul 31, 2025 Aug 4, 2025 Larimar Therapeutics, Inc. Director Buy 100.0 +9,375,000 44.16% ✗ $30M
Oct 22, 2024 Oct 24, 2024 Nuvalent, Inc. Director Sell 15.0 -2,000,000 -10.00% ✗ $195.5M
Feb 16, 2024 Feb 16, 2024 Larimar Therapeutics, Inc. Director Buy 100.0 +4,290,617 25.33% ✗ $37.5M
Nov 3, 2022 Nov 7, 2022 Nuvalent, Inc. Director Buy 95.0 +650,000 3.36% ✗ $21.8M
Sep 16, 2022 Sep 20, 2022 Larimar Therapeutics, Inc. Director Buy 100.0 +11,111,108 190.58% ✗ $35M
Jun 6, 2022 Jun 8, 2022 Mirum Pharmaceuticals, Inc. 10% Owner Sell 20.0 -38,478 -1.17% ✗ $962.3K
Jul 9, 2021 Jul 13, 2021 Mirum Pharmaceuticals, Inc. 10% Owner Sell 17.5 -99,325 -2.94% ✗ $1.6M
Jul 2, 2021 Jul 7, 2021 Mirum Pharmaceuticals, Inc. 10% Owner Sell 17.5 -66,675 -1.93% ✗ $1.1M
Jun 30, 2021 Jul 2, 2021 Larimar Therapeutics, Inc. Director Buy 100.0 +685,710 13.33% ✗ $6M
Sep 29, 2020 Oct 1, 2020 CalciMedica, Inc. 10% Owner Buy 100.0 +1,562,500 536.08% ✗ $25M
Jan 29, 2020 Jan 31, 2020 Q32 Bio Inc. 10% Owner Sell 16.3 -518,827 -11.26% ✗ $8M
Jan 24, 2020 Jan 28, 2020 Q32 Bio Inc. 10% Owner Sell 15.0 -639,506 -12.19% ✗ $10M
Dec 24, 2019 Dec 27, 2019 Q32 Bio Inc. 10% Owner Sell 16.3 -350,000 -6.25% ✗ $7.7M
Dec 19, 2019 Dec 23, 2019 Q32 Bio Inc. 10% Owner Sell 17.5 -164,730 -2.86% ✗ $3.6M
Jul 22, 2019 Jul 24, 2019 Mirum Pharmaceuticals, Inc. 10% Owner Buy 100.0 +332,000 21.30% ✗ $5M
Apr 12, 2019 Apr 15, 2019 Q32 Bio Inc. Director Buy 100.0 +533,333 10.20% ✗ $12M
Apr 2, 2018 Apr 4, 2018 Q32 Bio Inc. Director Buy 100.0 +1,250,000 62.86% ✗ $20M
Feb 8, 2016 Feb 8, 2016 Editas Medicine, Inc. 10% Owner Buy 100.0 +100,000 11.70% ✗ $1.6M